Hualu Network Group
中文版
search
Home Page
About us
Our Values
Development Milestone
News
News
Products
Product List for API
Recommended API
Product List for Finished Drug
Product list for Chemicals and Intermediates
Contract Manufacturing
API and Pharmaceutical Intermediates
OTC and Generics
Investor Relation
PERIODIC REPORT
INTERIM REPORT
INVESTORS SERVICE
Contact Us
Contact Us
Investor Relation
Information transparency and trust in peers
Investor Relation
PERIODIC REPORT
INTERIM REPORT
INVESTORS SERVICE
INVESTORS SERVICE
Home Page
/
Investor Relation
/
INVESTORS SERVICE
05
2025-06
Overseas Regulatory Announcement-Announcement on Icosapent Ethyl Soft Capsules Having Obtained Drug Registration Certificate
14
2025-03
Announcement Notice of Board Meeting
Copyright © Shandong Xinhua Pharmaceutical Co., Ltd
鲁ICP备09066031号
鲁公安备案号 3703900200041
(鲁)-非经营性-2015-0068
Technical Support:CR DIGITAL
Xinhua Pharmaceutical
